Trials / Withdrawn
WithdrawnNCT03814135
Efficacy and Safety of Two Doses of Hipnos in the Treatment of Adults With Insomnia
Randomized, Double-blind, Double-dummy, National, Phase II Clinical Trial to Evaluate the Efficacy and Safety of Two Doses of Hipnos Medication in the Treatment of Adults With Insomnia
- Status
- Withdrawn
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- EMS · Industry
- Sex
- All
- Age
- 50 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the efficacy and safety of three doses of Hipnos medication in adults with insomnia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Hipnos 3 | 1 tablet, oral, once a day. |
| DRUG | Hipnos 5 | 1 tablet, oral, once a day. |
| OTHER | Hipnos 5 Placebo | 1 tablet, oral, once a day. |
| OTHER | Hipnos 3 Placebo | 1 tablet, oral, once a day. |
Timeline
- Start date
- 2021-01-01
- Primary completion
- 2022-02-01
- Completion
- 2022-03-01
- First posted
- 2019-01-23
- Last updated
- 2021-04-01
Source: ClinicalTrials.gov record NCT03814135. Inclusion in this directory is not an endorsement.